Seldon Capital’s Core Scientific CORZ Stock Holding History

Seldon Capital’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-297,600	Closed	-$4.18M	–	61
2024 Q4	$4.18M	Hold	297,600	–	–	1.71%	19
2024 Q3	$3.53M	Buy	+297,600	New	+$3.08M	1.99%	16

Other funds holding CORZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

Gullane Capital Memphis, Tennessee $37.4M AUM 112.18% 1-Year Est. Return

OWP

ORG Wealth Partners Dallas, Texas $508M AUM 83.62% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

JCM

JAT Capital Management Greenwich, Connecticut $59.3M AUM 134.04% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HPM

Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return

Seldon Capital's CORZ Position: Q1 2025 in Review

Seldon Capital sold out of Core Scientific (CORZ) in Q1 2025, closing a stake of 297,600 shares — an estimated $4.18M sold.

Seldon Capital first reported a position in CORZ in Q3 2024 and held it in 2 quarters. The position peaked at $4.18M in Q4 2024. 336 funds tracked by Wall St. Rank hold CORZ as of Q1 2025.

Seldon Capital reported no remaining Core Scientific position as of Q1 2025 after selling out during the quarter.
Seldon Capital sold 297,600 Core Scientific shares in Q1 2025, an estimated $4.18M.
Seldon Capital first reported a position in Core Scientific in Q3 2024 and held it in 2 quarters.
Seldon Capital's Core Scientific position peaked at $4.18M in Q4 2024.
336 funds tracked by Wall St. Rank held Core Scientific as of Q1 2025.

Based on Seldon Capital's 13F filing for Q1 2025, filed 15 May 2025.